SGHT TearCare gains first-only MGD indication for evaporative dry eye
SGHT says its TearCare is the first and only treatment indicated to improve meibomian gland function in patients with evaporative dry eye disease.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.